U.S. lawmakers ramp up scrutiny of FDA following agency’s approval of controversial Alzheimer’s drug
By
Alicia Lasek
Sep 07, 2021
The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
To save itself, might Medicare deny coverage of controversial new Alzheimer’s drug?
By
Kimberly Marselas
Jun 28, 2021
The true price to administer aducanumab — a controversial new Alzheimer’s treatment — may actually be closer to $100,000 annually than other, lower estimates and is just one reason the Centers for...
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
‘Surprising’ study results find moderate exercise may worsen Alzheimer’s
By
Kimberly Marselas
May 18, 2018
Moderate exercise, long thought to be a tool in the battle against Alzheimer’s disease, may actually hasten symptoms if done regularly after diagnosis, a new study suggests.
Want to ward off dementia? Follow Madonna’s lead
By
May 17, 2016
If you really want to help cut your risks of cognitive impairment and memory loss, it might be time to go outside your comfort zone and take a few tips from the Material Girl herself.
Cues from canines in dementia research
By
Elizabeth Newman
Feb 12, 2016
There’s debate in the Leis/Newman households over the intelligence of the family basset hound, Daisy Mae. My mother believes Daisy Mae is purely food-driven, rather than intellectually gifted. I...
‘The Best Days’ — a best read
By
James M. Berklan
Apr 02, 2014
Where to start when discussing Jean Rene Champion’s engrossing memoir is a difficult question, rivaled only by the struggle of where to stop. His self-published “The Best Days of My Life: Memories...
An Alzheimer’s reality check
By
Tim Mullaney
Nov 12, 2013
Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...